Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CERE | MDGL | CORT | ||
| Company | Cerevel Therapeutics Hldg Inc | Madrigal Pharmaceuticals Inc | Corcept Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 44.99 | 513.00 | 60.00 | ||
| High | 44.99 | 520.89 | 60.95 | ||
| Low | 44.96 | 507.05 | 59.54 | ||
| Latest | 44.96 | 517.26 | 60.22 | ||
| Change | +0.33 | +3.67 | +0.53 | ||
| % Change | +0.74% | +0.71% | +0.89% | ||
| Volume | 15,096,300 | 160,800 | 536,100 | ||
| 20-Day Average Volume | 2,839,210 | 283,030 | 1,260,155 | ||
| Previous Close | 44.63 | 513.59 | 59.69 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 42.53 | 518.02 | 53.11 | ||
| 20-Day Raw Stochastic | 99.49% | 39.39% | 95.21% | ||
| 20-Day Relative Strength | 68.05 | 51.53 | 71.90 | ||
| Weighted Alpha | +49.03 | +73.58 | +44.28 | ||
| Today's Opinion | 72% Buy | 88% Buy | 40% Buy | ||
| Previous Opinion | 72% Buy | 88% Buy | 40% Buy | ||
| Last Month's Opinion | 8% Buy | 56% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.67% since 07/24/24 | -1.23% since 05/15/26 | +6.83% since 05/15/26 | ||
| Low | 43.75 on 07/25/24 | 499.34 on 05/20/26 | 54.59 on 05/19/26 | ||
| High | 44.99 on 07/31/24 | 528.99 on 05/19/26 | 60.95 on 05/22/26 | ||
| 1-Month | |||||
| %Chg | +9.95% since 06/28/24 | -2.25% since 04/22/26 | +29.31% since 04/22/26 | ||
| Low | 39.16 on 07/03/24 | 490.13 on 05/12/26 | 44.24 on 04/23/26 | ||
| High | 44.99 on 07/31/24 | 559.00 on 05/06/26 | 60.95 on 05/22/26 | ||
| 3-Month | |||||
| %Chg | +5.27% since 04/30/24 | +18.91% since 02/20/26 | +72.95% since 02/20/26 | ||
| Low | 38.50 on 06/25/24 | 416.21 on 03/03/26 | 31.81 on 03/13/26 | ||
| High | 44.99 on 07/31/24 | 572.20 on 03/26/26 | 60.95 on 05/22/26 | ||
| 6-Month | |||||
| %Chg | +6.82% since 01/30/24 | -5.60% since 11/21/25 | -22.09% since 11/21/25 | ||
| Low | 38.50 on 06/25/24 | 416.21 on 03/03/26 | 28.66 on 02/19/26 | ||
| High | 44.99 on 07/31/24 | 615.00 on 12/24/25 | 89.00 on 12/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,191,488 | 11,925,941 | 6,464,737 | ||
| Shares Outstanding, K | 182,195 | 23,056 | 107,352 | ||
| Annual Sales | 0 | 958,400,000 | 761,410,000 | ||
| Annual Net Income | -432,840,000 | -288,280,000 | 99,650,000 | ||
| Last Quarter Sales | 0 | 311,340,000 | 164,900,000 | ||
| Last Quarter Net Income | -131,910,000 | -94,390,000 | -31,760,000 | ||
| 60-Month Beta | 1.40 | -1.04 | 0.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 05/08/24 | -3.25 on 05/06/26 | -0.30 on 04/30/26 | ||
| Earnings Date | 08/07/24 | 08/04/26 | 07/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 170.54 | ||